Literature DB >> 11056429

Stevens-Johnson syndrome-like exanthema secondary to methotrexate histologically simulating acute graft-versus-host disease.

N Hani1, C Casper, W Groth, T Krieg, N Hunzelmann.   

Abstract

A 61 year old male patient suffering from psoriasis vulgaris developed a severe skin reaction with toxic myelosuppression three days after administration of 20 mg methotrexate (MTX) p.o. per week and concomitant 100 mg acetylic salicylic acid (ASA) per day. The skin lesions simulated Stevens-Johnson syndrome with ulcerations of the oral mucosa and erythema multiforme-like target lesions. The histology of the epidermis resembled an acute graft-versus-host reaction. The increased toxic effect of MTX on keratinocytes in our patient was most likely caused by a lowered plasma binding capacity and reduced renal excretion of MTX due to concomitant administration of ASA. Thus in the treatment of severe forms of psoriasis with MTX, the combined administration of drugs aggravating MTX toxicity, particularly of ASA, should be carefully considered, due to the increased toxicity and risk of severe skin reactions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11056429

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  4 in total

1.  Acute mucocutaneous methotrexate toxicity with marked tissue eosinophilia.

Authors:  Luis J Borda; Andrew Ross; Gabriel Villada; Clara Milikowski
Journal:  BMJ Case Rep       Date:  2018-04-07

2.  Severe skin toxicity in pediatric oncology patients treated with voriconazole and concomitant methotrexate.

Authors:  Johan G C van Hasselt; Natasha K A van Eijkelenburg; Alwin D R Huitema; Jan H M Schellens; Antoinette Y N Schouten-van Meeteren
Journal:  Antimicrob Agents Chemother       Date:  2013-04-09       Impact factor: 5.191

3.  miR-542-3p Attenuates Bone Loss and Marrow Adiposity Following Methotrexate Treatment by Targeting sFRP-1 and Smurf2.

Authors:  Ya-Li Zhang; Liang Liu; Yu-Wen Su; Cory J Xian
Journal:  Int J Mol Sci       Date:  2021-10-12       Impact factor: 5.923

4.  miR-6315 Attenuates Methotrexate Treatment-Induced Decreased Osteogenesis and Increased Adipogenesis Potentially through Modulating TGF-β/Smad2 Signalling.

Authors:  Ya-Li Zhang; Liang Liu; Yu-Wen Su; Cory J Xian
Journal:  Biomedicines       Date:  2021-12-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.